ABSTRACT
An experimental study and kinetic model analysis of the initiated chemical vapor deposition (iCVD) of polymer thin films have been performed at saturated monomer vapor conditions. Previous iCVD kinetic studies have focused on subsaturated monomer conditions where polymer deposition kinetics is known to be limited by monomer adsorption. However, iCVD kinetics at saturated conditions have so far not been systematically investigated, and it remains unclear whether the adsorption-limited phenomenon would still apply at saturation, given the abundance of monomer for reaction. To probe this question, a series of depositions of poly(vinylpyrrolidone) (PVP) thin films as a model system were performed by iCVD at substrate temperatures from 10 to 25 °C at both fully saturated (100%) and subsaturated (50%) conditions. While the deposition rates at subsaturated conditions exhibit the expected adsorption-limited behavior, the deposition rates at saturated conditions unexpectedly show two distinct deposition regimes with reaction time: an initial adsorption-limited regime followed by a kinetically limited steady-state regime. In the steady-state regime, the deposition kinetics is found to be thermally activated by raising substrate temperature with an overall activation energy of +86 kJ/mol, which agrees reasonably well with the experimentally determined value of +89 kJ/mol in the literature for bulk PVP polymerization and a mechanistically derived value of +91 kJ/mol based on the bulk free radical polymerization mechanism of PVP. These findings open new operating windows for iCVD polymerization and thin-film growth in which fast polymer deposition can be achieved without substrate cooling that can greatly simplify the iCVD scale-up to roll-to-roll processing and enable iCVD polymerization of highly volatile monomers relevant for diverse applications in biomedicine, smart wearables, and renewable energy.
ABSTRACT
Membrane-mediated assembly has been well characterised for toxic amyloid species such as the amyloid-ß peptide implicated in Alzheimer's disease. However, little is known about the membrane-mediated assembly of functional-amyloid forming peptides, recently identified as a natural storage state for neuropeptide hormones in vivo. Here, we study the aggregation of somatostatin-14 (SST-14) co-incubated with model lipid membranes. Atomic force microscopy (AFM) studies confirmed that nanofibrils formed in the presence of various lipid membranes display reduced fibrillogenesis and promote the formation of non-fibrillar oligomers. Both circular dichroism (CD) and intrinsic tryptophan fluorescence studies confirmed interaction between the peptide and the lipid bilayer; this interaction appears to drive changes in membrane-mediated aggregation kinetics. We show that both the surface charge of the membrane and chain packing drive changes in the electrostatic and hydrophobic interactions between the peptide and the membrane, and hence the rate of assembly. The similarities in the effect of the lipid membrane on aggregation of functional amyloids and the more well studied toxic amyloids suggest strong aggregation modifying lipid bilayer interactions are a ubiquitous feature of all amyloid fibrils and highlight the need for further investigation as to why this leads to toxicity in some systems and not others.
